stockrow
Friday 6 November 2026
Export VERA’s income statement to Excel — free account
Vera Therapeutics, Inc.
VERA Healthcare Biotechnology
- EPS
- −26.7%
- Free cash flow
- −82.5%
- Total debt
- +1.03%
Quarter to June 2026, against a year earlier
30.12
0.02
−0.07%
Follow VERA
Alert me
Vera Therapeutics, Inc. (VERA) Current ratio
Vera Therapeutics, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 10.9×, down 2.7× from fiscal 2025 (13.6×). Over the past ten years it has ranged from 3.4× (fiscal 2019) to 25.7× (fiscal 2024); the current reading is higher than 71% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 13.6× | (46.88%) |
| FY2024 | 25.7× | 232.79% |
| FY2023 | 7.7× | 57.08% |
| FY2022 | 4.9× | (54.25%) |
| FY2021 | 10.7× | (52.41%) |
| FY2020 | 22.6× | 570.56% |
| FY2019 | 3.4× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 10.9× | (19.96%) |
| Mar 2026 | 13.6× | 0.03% |
| Dec 2025 | 13.6× | 11.68% |
| Sep 2025 | 12.2× | (28.30%) |
| 20 more quarters | Free account |
Against its own ten years
Low 3.4×
High 25.7×
Ten-year median
10.7×
Current reading's percentile
71
Current ratio against peers
| Company | Current ratio |
|---|---|
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | 32.8× |
| PVLA Palvella Therapeutics, Inc. compare | 21.2× |
| IMNM Immunome, Inc. compare | 15.1× |
| CLDX Celldex Therapeutics, Inc. compare | 11.8× |
| VERA Vera Therapeutics, Inc. | 10.9× |
| AUPH Aurinia Pharmaceuticals Inc compare | 6.1× |
| ADMA ADMA Biologics Inc compare | 6.0× |
| VCEL Vericel Corporation compare | 5.1× |
| BHVN Biohaven Ltd. compare | 3.1× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)